tiprankstipranks
Trending News
More News >
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH

Compare Aurinia Pharmaceuticals (AUPH) vs. Competitors

Compare
2,110 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Aurinia Pharmaceuticals
$14.85
$1.96B
26.47
91.86%
3 Buy
3 Hold
0 Sell
Moderate Buy
BioCryst
$6.66
$1.40B
-140.80
-5.67%
8 Buy
2 Hold
0 Sell
Strong Buy
Celldex
$25.65
$1.70B
-7.58
12.70%
9 Buy
0 Hold
1 Sell
Strong Buy
MannKind
$5.21
$1.60B
55.25
-13.31%
6 Buy
0 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$21.13
$2.21B
-7.31
-81.95%
5 Buy
10 Hold
4 Sell
Hold
Immunocore Holdings
$33.35
$1.68B
-57.09
14.60%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AUPH
Aurinia Pharmaceuticals
14.85
7.12
92.11%
BCRX
BioCryst
6.66
-0.95
-12.48%
CLDX
Celldex
25.65
1.04
4.23%
MNKD
MannKind
5.21
-0.83
-13.74%
SRPT
Sarepta Therapeutics
21.13
-95.66
-81.91%
IMCR
Immunocore Holdings
33.35
3.35
11.17%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts